gvtcx

NATIONAL FRAMEWORK AGREEMENT FOR THE SUPPLY OF HUMAN NORMAL IMMUNOGLOBULIN AND ANTI-D IMMUNOGLOBULIN

HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST Published 8 Sept 2021 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£188,608
Statuscomplete
Category (CPV) 33141510 +2 more
RegionYorkshire and the Humber
Deadline1 Jun 2021
Contract start1 Jul 2021
Contract end30 Jun 2023
Procedureselective
SME suitableYes
OCIDocds-b5fd17-622c87fd-ec26-418a-97c2-4fe18bb068d1

Awards (2)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is £188,608.

SupplierValueDateStatus
BIO PRODUCTS LABORATORY LIMITED shared £188,608 27 Jun 2021 active
CSL BEHRING UK LIMITED shared £188,608 27 Jun 2021 active

description

This is a publication to Award a Contract to BIO PRODUCTS LABORATORY and CSL BEHRING (UK) LIMITED for the Hull University Teaching Hospital to Access the products of Human Normal Immunoglobulin and Anti-D Immunoglobulin utilising the NHS England Commercial Medicines Unit (CMU) National Framework Agreement for Human Normal Immunoglobulin and Anti-D Immunoglobulin - Reference Number: CM/PMS/17/5550.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
8 Sept 2021 Award (award) · 3894561c-2b4f-4f70-8542-53b9fb06d011-467010

more from HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.